Key Record Dates
ClinicalTrials.gov Identifier: | NCT05409066 |
---|---|
Brief Title: | Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Follicular Lymphoma (EPCORE FL-1) |
First Submitted : | June 3, 2022 |
First Submitted that Met QC Criteria : | June 3, 2022 |
First Posted : | June 8, 2022 |
Last Update Submitted that Met QC Criteria : | May 6, 2024 |
Last Update Posted : | May 7, 2024 |